Skip to main content

Table 1 Baseline characteristics of enrolled patients

From: Markers of increased atherosclerotic risk in patients with chronic kidney disease: a preliminary study

Table 1 CKD Stages I-V Control group p
N=80 N=24
Age 67.2 ± 11.7 61.2 ± 9.6 0.042
Gender (males %) 56.2% 29.2% 0.01
Diabetes mellitus 33.3% 0% 0.0022
Atrial fibrillation 20.83% 13.79% NS
Hypertension 88.3% 37.5% <0.0001
Lipid disorders 30.6% 41.4% 0.039
Heart failure 63.9% 0% <0.0001
Hypertensive nephropathy 5.6% 0% NS
Diabetic nephropathy 4.2% 0% NS
Beta-blockers 61% 20,8% <0.007
CA-blockers 40.5% 8.3% 0.004
ACE inhibitors 69.6% 41% 0.011
Diuretics 90.5% 16.7% <0.0001
Statins 97.5% 43% <0.0001
Erythropoietina 5.6%a 0% <0.0001
Mean dialysis vintage [months]a 27±9a 0 <0.0001
  1. a applies only to CKD stage V patients